Bayer Aktie 10367293 / DE000BAY0017
51.46
CHF
-0.15
CHF
-0.29%
18:00:00
BRX
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch | Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99.96 |
Temasek Holdings Pte Ltd. (Investment Management) | 3.52 |
Norges Bank Investment Management | 3.15 |
Harris Associates LP | 2.99 |
Government Pension Fund - Global (The) | 2.77 |
Vanguard Total International Stock Index Fund | 1.32 |
Dodge & Cox International Stock Fund | 1.21 |
Oakmark International Fund | 0.85 |
Vanguard Developed Markets Index Fund | 0.78 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 116'998 | 103'824 | 99'538 | 99'637 | 101'369 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.34 | 0.42 | 0.42 | 0.44 | 0.50 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 32'197 | 31'760 | 35'002 | 31'994 | 37'247 |
Summe Anlagevermögen | 87'199 | 86'308 | 72'154 | 73'823 | 80'235 |
Summe Aktiva | 131'439 | 131'327 | 122'850 | 126'778 | 130'884 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 41'222 | 38'971 | 41'630 | 40'803 | 41'462 |
Summe Fremdkapital | 85'291 | 83'810 | 92'151 | 93'610 | 91'958 |
Summe Eigenkapital | 46'148 | 47'517 | 30'699 | 33'168 | 38'926 |
Summe Passiva | 131'439 | 131'327 | 122'850 | 126'778 | 130'884 |
Adresse
Kaiser-Wilhelm-Allee 1, 51368 Leverkusen | |
Telefon | +49 (214) 30-1 |
URL | http://www.bayer.com |
Management
Alan Schultz
Head-North America Project Procurement |
Alberto Weisser
Independent Member-Supervisory Board |
Andrea Sacher
Member-Supervisory Board |
André van Broich
Member-Supervisory Board |
Barbara Gansewendt
Member-Supervisory Board |
Bijoy Sagar
Chief Information Technology Officer |
Christian Rommel
Head-Research & Development |
Claudia Schade
Member-Supervisory Board |
Colleen A. Goggins
Independent Member-Supervisory Board |
Ertharin Cousin
Independent Member-Supervisory Board |
Francesco Grioli
Member-Supervisory Board |
Frank Löllgen
Member-Supervisory Board |
Frank Rittgen
Head-Mergers & Acquisitions |
Heike Hausfeld
Vice Chairman-Supervisory Board |
Heiko Willem-Jan Schipper
Member-Management Board |
Heinz Georg Webers
Member-Supervisory Board |
Horst Heinz Paul Baier
Independent Member-Supervisory Board |
Itziar Canamasas
Head-Oncology Europe, Middle East & Africa |
Kimberly Mathisen
Member-Supervisory Board |
Marianne de Backer
EVP & Head-Global Business Development & Licensing |
Michael Westmeier
Member-Supervisory Board |
Norbert W. Bischofberger
Independent Member-Supervisory Board |
Norbert Winkeljohann
Chairman-Supervisory Board |
Oliver Maier
Head-Investor Relations |
Otmar D. Wiestler
Independent Member-Supervisory Board |
Paul Achleitner
Member-Supervisory Board |
Rodrigo Santos
President-Crop Science Division |
Ruzha Draganova
Global HR Business Partner |
Sarena S. Lin
Chief Transformation & Talent Officer |
Simone Bagel-Trah
Member-Supervisory Board |
Stefan Oelrich
President-Pharmaceuticals Division |
Thomas Hoffmann
Head-Treasury |
Werner Baumann
Chairman-Management Board & CEO |
Wolfgang U. Nickl
Head-Finance |
Yasmin Fahimi
Member-Supervisory Board |